These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 4698026)
1. [Phenytoin--blood levels and clinical aspects]. Strandfjord RE; Johannessen SI Tidsskr Nor Laegeforen; 1973 Feb; 93(6):395-8. PubMed ID: 4698026 [No Abstract] [Full Text] [Related]
2. [Dynamics of the serum level increase of hydantoins following the begin of oral administration]. Zouhar A; Hrazdira CL; Hrazdirová V; Skálová M Cesk Neurol Neurochir; 1975 May; 38(3):146-50. PubMed ID: 1132023 [No Abstract] [Full Text] [Related]
3. [Diphenylhydantoin poisoning due to diphenylhydantoin-isoniazid interaction]. Geering JM; Ruch W; Dettli L Schweiz Med Wochenschr; 1974 Aug; 104(35):1224-8. PubMed ID: 4445849 [No Abstract] [Full Text] [Related]
4. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings]. Denegri M; Luciano L Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027 [No Abstract] [Full Text] [Related]
9. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy. Strandjord RE; Johannessen SI Acta Neurol Scand Suppl; 1972; 51():499-500. PubMed ID: 4514392 [No Abstract] [Full Text] [Related]
10. [Phenytoin pharmacokinetics as a function of the preparation: capsules, commercial tablets and experimental tablets]. Almaşu I; Leucuţa SE Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1986; 31(4):283-93. PubMed ID: 2951833 [No Abstract] [Full Text] [Related]
11. [Clinical significance of blood levels of diphenylhydantoin orally administered to epileptic patients]. Ma ZZ Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):136-8. PubMed ID: 4053817 [No Abstract] [Full Text] [Related]
13. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose. Su CM; Kung CT; Wang YC; Lu CH Neurol India; 2009; 57(2):200-2. PubMed ID: 19439856 [TBL] [Abstract][Full Text] [Related]
14. One daily dose of diphenylhydantoin for patients with epilepsy. Strandjord RE; Johannessen SI; Halpern LM Epilepsia; 1974 Sep; 15(3):317-27. PubMed ID: 4527914 [No Abstract] [Full Text] [Related]
15. Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate. Lecchini S; Gatti G; De Bernardi M; Caravaggi M; Frigo GM; Calzetti S; Visintini D Farmaco Prat; 1978 Feb; 33(2):80-2. PubMed ID: 344060 [No Abstract] [Full Text] [Related]
16. Drug estimation in the treatment of epilepsy. Richens A Proc R Soc Med; 1974 Dec; 67(12 Pt 1):1227-9. PubMed ID: 4449865 [No Abstract] [Full Text] [Related]
19. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects. Buchthal F; Svensmark O Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709 [No Abstract] [Full Text] [Related]
20. A method for shifting from oral to intramuscular diphenylhydantoin administration. Wilder BJ; Serrano EE; Ramsey E; Buchanan RA Clin Pharmacol Ther; 1974 Sep; 16(3):507-13. PubMed ID: 4411662 [No Abstract] [Full Text] [Related] [Next] [New Search]